| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Neuberger J | |
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis | Q33745849 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study | Q41916901 | ||
| Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid | Q43893454 | ||
| Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis | Q58376775 | ||
| Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? | Q69896715 | ||
| Ursodeoxycholic acid for primary biliary cirrhosis | Q73186060 | ||
| Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications | Q77598543 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 1027-1028 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | URSO-panacea or placebo? | |
| P478 | volume | 31 |
| Q35596580 | Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort |
| Q44008018 | Disruption of mitochondrial calcium homeostasis after chronic alpha-naphthylisothiocyanate administration: relevance for cholestasis |
| Q43868844 | Interactions of combined bile acids on hepatocyte viability: cytoprotection or synergism. |
| Q28141076 | Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management |
| Q79240270 | Liver transplantation for primary biliary cirrhosis |
| Q44278008 | Mitochondrially mediated synergistic cell killing by bile acids. |
| Q34354186 | Options for treatment of primary biliary cirrhosis |
| Q35573929 | Primary biliary cirrhosis: specific treatment |
| Q42699460 | The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: hype or hope? |
| Q43561664 | Ursodeooxycholic acid for primary biliary cirrhosis |
| Q34330984 | Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. |
| Q77784964 | [New therapeutic strategies in liver fibrosis: pathogenic basis] |
Search more.